No Data
No Data
Express News | LakeShore Biopharma Initiates Biologics License Application Of PIKA Rabies Vaccine To The Drug Regulatory Authority Of Pakistan
12 Health Care Stocks Moving In Tuesday's Intraday Session
Lacklustre Performance Is Driving LakeShore Biopharma Co., Ltd's (NASDAQ:LSB) 66% Price Drop
LakeShore Biopharma Regains Compliance With Nasdaq Minimum Bid Price Requirement
LakeShore Biopharma Advances With Rabies Vaccine Trial
Express News | LakeShore Biopharma Receives Phase III Trial Approval In China For Simplified Four-Dose YSJA Rabies Vaccine Regimen; Aims To Enhance Patient Adherence And Reduce Costs While Maintaining Immunogenicity
No Data
No Data